APA
NTLA icon

American Portfolios Advisors’s Intellia Therapeutics NTLA Stock Holding History

American Portfolios Advisors’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$809K Sell
14,450
-682
-5% -$42.3K 0.03% 487
2022
Q2 		$783K Sell
15,132
-419
-3% -$21.3K 0.03% 503
2022
Q1 		$1.13M Sell
15,551
-1,820
-10% -$154K 0.04% 446
2021
Q4 		$2.05M Buy
17,371
+915
+6% +$115K 0.07% 275
2021
Q3 		$2.21M Sell
16,456
-1,738
-10% -$263K 0.08% 249
2021
Q2 		$2.95M Sell
18,194
-10,019
-36% -$780K 0.11% 181
2021
Q1 		$2.26M Buy
28,213
+4,910
+21% +$330K 0.1% 201
2020
Q4 		$1.27M Buy
23,303
+9,369
+67% +$340K 0.06% 285
2020
Q3 		$277K Buy
13,934
+7,806
+127% +$163K 0.02% 684
2020
Q2 		$129K Buy
6,128
+4,728
+338% +$80.3K 0.01% 911
2020
Q1 		$17.1K Buy
1,400
+1,041
+290% +$14K ﹤0.01% 1588
2019
Q4 		$5.27K Hold
359
– – ﹤0.01% 2257
2019
Q3 		$4.79K Sell
359
-100
-22% -$1.59K ﹤0.01% 2213
2019
Q2 		$7.51K Hold
459
– – ﹤0.01% 2017
2019
Q1 		$7.84K Hold
459
– – ﹤0.01% 1920
2018
Q4 		$6.26K Sell
459
-130
-22% -$2.42K ﹤0.01% 1792
2018
Q3 		$16.9K Hold
589
– – ﹤0.01% 1552
2018
Q2 		$16.1K Buy
589
+464
+371% +$11.2K ﹤0.01% 1536
2018
Q1 		$2.64K Buy
+125
New +$3.07K ﹤0.01% 2042

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Portfolios Advisors's NTLA Position: Q3 2022 in Review

American Portfolios Advisors reduced its Intellia Therapeutics (NTLA) stake by 4.5% in Q3 2022, selling an estimated $42.3K and leaving 14,450 shares worth $809K. The position accounts for 0.03% of the portfolio, ranked #487.

American Portfolios Advisors first reported a position in NTLA in Q1 2018 and has held it in 19 quarters since. The position peaked at $2.95M in Q2 2021. 320 funds tracked by Wall St. Rank hold NTLA as of Q3 2022.

  • American Portfolios Advisors held 14,450 shares of Intellia Therapeutics worth $809K as of Q3 2022.
  • American Portfolios Advisors sold 682 Intellia Therapeutics shares in Q3 2022, an estimated $42.3K.
  • Intellia Therapeutics made up 0.03% of American Portfolios Advisors's portfolio in Q3 2022, its #487 holding.
  • American Portfolios Advisors first reported a position in Intellia Therapeutics in Q1 2018 and has held it in 19 quarters since.
  • American Portfolios Advisors's Intellia Therapeutics position peaked at $2.95M in Q2 2021.
  • 320 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.